The successful completion of an in vivo therapeutic trial using innovative CRISPR-based technologies to target the African swine fever virus in pigs demonstrated pigs infected with ASFV and treated with Seek Labs’ CRISPR-based systems survived longer than untreated infected pigs. Over half of the CRISPR-treated pigs survived beyond the duration of the trial.
Source: businesswire, May 6, 2024. Link.
With no available treatments for African Swine Fever, this is a breakthrough discovery. These are excellent results that indicate the potential to dramatically increase survivability in pigs against ASFV infection and treat other animal diseases.” – Doug Gladue, PhD